The company says it expects to have mFlusiva ready for the upcoming 2026-2027 flu season, which runs from roughly October to May.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Evercore ISI analysts said in a note they “see no meaningful revenue opportunity” for Moderna in hantaviruses.
Operational revenue from Pfizer’s Covid vaccine Comirnaty and Paxlovid pill to treat the illness declined 59% and 63%, respectively.
The e-bike industry has spent the last year in a Chapter 11 shredder, but a new “War Economy” at the pump is changing the math.
Mixing politics and investing is like mixing emotions and math: It rarely adds up.
The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US patients.
Wealth managers are sifting through the rhetoric and focusing on financial planning.
Gritstone Bio announced it is “taking action” to “preserve value and strengthen capital structure” on Thursday.